- Home
- ORKA vs AMSF Comparison
ORKA vs AMSF Comparison
Compare ORKA & AMSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORKA | AMSF |
|---|---|---|
| Founded | 2004 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Accident &Health Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 616.3M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | ORKA | AMSF |
|---|---|---|
| Price | $45.44 | $32.98 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 3 |
| Target Price | ★ $57.25 | $50.33 |
| AVG Volume (30 Days) | ★ 504.1K | 187.9K |
| Earning Date | 03-12-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 8.05% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.47 |
| Revenue | N/A | ★ $317,252,000.00 |
| Revenue This Year | N/A | $8.06 |
| Revenue Next Year | N/A | $6.34 |
| P/E Ratio | ★ N/A | $13.28 |
| Revenue Growth | N/A | ★ 2.66 |
| 52 Week Low | $5.49 | $32.00 |
| 52 Week High | $45.52 | $53.27 |
Technical Indicators
Market Signals| Indicator | ORKA | AMSF |
|---|---|---|
| Relative Strength Index (RSI) | 69.55 | 37.82 |
| Support Level | $26.02 | $32.08 |
| Resistance Level | N/A | $33.74 |
| Average True Range (ATR) | 3.21 | 0.71 |
| MACD | 0.73 | 0.11 |
| Stochastic Oscillator | 89.39 | 39.45 |
Price Performance
Historical ComparisonAbout ORKA Oruka Therapeutics Inc.
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
About AMSF AMERISAFE Inc.
AMERISAFE Inc is a specialty provider of workers' compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, agriculture, manufacturing, maritime, and telecommunications. The company generates a majority of its revenue in the form of premiums. The Company operates as a single reportable segment, Insurance Operations.